Cost-effectiveness of Peginterferon plus Ribavirin in a Real-World Population of Patients with Chronic Hepatitis C and Associated Comorbidities

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions